Category: Raleigh-Durham, North Carolina Local News

HOLLYWOOD — Netflix is declining to raise its offer to buy Warner Bros. Discovery’s studio and streaming business, in a stunning move that effectively puts Paramount in a position to take over the fellow storied Hollywood giant.

On Thursday, after Warner’s board announced that Skydance-owned Paramount’s offer was superior to the agreement it had previously struck with Netflix, the streaming giant said the new price that would be required to buy Warner would make it a deal that is “no longer financially attractive.”

Unlike Netflix’s bid, Paramount wants all of Warner’s operations, including networks like CNN and Discovery. That would put CNN under the same roof as Paramount’s CBS and combine two of Hollywood’s last five remaining studios.

The owner of HBO Max, DC Studios and popular titles like “Harry Potter” had backed Netflix’s proposal for months. But after Skydance-owned Paramount upped its rival bid for the entire company to $31 per share, in addition to other revisions, Warner’s board on Thursday said that the offer “constitutes a ‘company superior proposal.’”

A Paramount buyout Warner’s business would vastly reshape Hollywood and the wider media landscape. Paramount’s CBS has seen significant editorial shifts, notably with the installation of Free Press founder Bari Weiss at CBS News, under new Skydance ownership. And if Paramount’s acquisition of Warner is successful, many expect the reach of those changes to only grow.

A Paramount-Warner combo would also combine two of Hollywood’s five legacy studios that remain today, in addition to their theatrical channels. Beyond “Harry Potter,” Warner movies like “Superman,” “Barbie,” and “One Battle After Another” – as well as hit TV series like “The White Lotus” and “Succession” – would join Paramount’s content library.

Today, Paramount’s lineup of titles include “Top Gun,” “Titanic” and “The Godfather.” And beyond CBS, it owns networks like MTV and Nickelodeon, as well as the Paramount+ streaming service.

Executives at Paramount have argued that merging will be good for consumers and the wider industry. But lawmakers and entertainment trade groups have sounded the alarm – warning that a Warner takeover would only further consolidate power in an industry already run by just a few major players. Critics say that could result in job losses, less diversity in filmmaking and potentially more headaches for consumers who are facing rising costs of streaming subscriptions as is.

Combined, that raises tremendous antitrust concerns. The U.S. Department of Justice has already initiated reviews, and other countries are expected to do so, too.

Netflix, Warner and Paramount have spent the last couple of months in a heated, public back and forth over whose deal has a better regulatory path – and offers more value for Warner shareholders. Thursday’s announcement arrived shortly after Paramount upped the ante on its offer.

Beyond increasing its proposed purchase price for Warner, the company also agreed to a regulatory termination fee of $7 billion. And Paramount pledged to move up a previously-promised “ticking fee.” The company initially said it would pay 25 cents per share for every quarter the deal drags on past the end of the year. Now it’s agreed to pay that amount if the deal doesn’t go through by the end of September, Warner said.

But Paramount is taking on billions of dollars in debt to finance its offer. And David Ellison’s father, Oracle founder Larry Ellison, is heavily backing the bid for his son’s company. Foreign sovereign wealth funds have also provided equity for the offer, drawing scrutiny.

The Ellisons also have a close relationship with President Donald Trump – bringing more politics into question. Trump previously made unprecedented suggestions about his involvement in seeing a deal through, before walking back those statements and maintaining that regulatory approval will be up to the Justice Department.

The push to acquire Warner also arrives just months after Skydance closed its own buyout of Paramount – in a contentious merger approved just weeks after the company agreed to pay the president $16 million to settle a lawsuit over editing at CBS’ “60 Minutes” program. Still, Trump has continued to publicly lash out at Paramount and “60 Minutes” since.

HENDERSON COUNTY, N.C. — A North Carolina woman indicted on murder charges after she allegedly poisoned family members with wine during a Thanksgiving dinner could face the death penalty.

On Tuesday, Feb. 17, the office of District Attorney Andrew Murray filed a motion to hold a Rule 24 pretrial conference in the case of Gudrun Linda Jean Casper-Leinenkugel. A Rule 24 hearing in North Carolina is mandatory for cases where the defendant is charged with a crime punishable by death, as is the case for Casper-Leinenkugel.

Casper-Leinenkugel, 52, is charged with two counts of first-degree murder, two counts of attempted first-degree murder and multiple counts of distributing a prohibited food or beverage, according to arrest warrants.

Court records allege Casper-Leinenkugel killed her daughter, Leela Jean Livis, and is responsible for the 2007 death of Michael Schmidt, both by poisoning. Investigators also allege she attempted to kill her other daughter, Mia Lacey, and Lacey’s boyfriend, Richard Pegg, during a Thanksgiving gathering in November 2025.

Sheriff’s investigators say the wine served during that meal was allegedly laced with acetonitrile, an industrial solvent that converts into cyanide once ingested. Warrants charge Casper-Leinenkugel with knowingly distributing a beverage containing the toxic chemical, which authorities say caused death or serious physical injury.

The warrants state the alleged poisoning of Schmidt occurred in October 2007, while the more recent allegations involve the 2025 Thanksgiving gathering in Henderson County.

Casper-Leinenkugel is being held without bond and is scheduled for a court hearing on Thursday, Feb. 26.

The-CNN-Wire & 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.

U.S. childhood and teen obesity rates have reached record-highs while adult obesity rates may be slowing, according to two new reports published early Wednesday by the Centers for Disease Control and Prevention (CDC).

Researchers used measured heights and weights from the National Health and Nutrition Examination Survey (NHANES) — run by the CDC’s National Center for Health Statistics — to track trends over more than six decades.

In the first report, the team found that, in the most recent survey conducted between August 2021 and August 2023, 40.3% of adults aged 20 and older were found to be obese, including 9.7% with severe obesity and another 31.7% classified as overweight.

By comparison, for the survey conducted between 1988 and 1994, 22.9% adults aged 20 and older were found to be obese including 2.8% with severe obesity and 33.1% classified as overweight.

However, some of the newest estimates suggest the rapid rise seen in earlier decades may be slowing slightly.

In the 2017-2018 survey, 42.4% of adults were classified as obese, which is the highest figure ever recorded. The decrease between the two most recent surveys could be indicative of a downward trend. Dr. John Brownstein, an epidemiologist and chief innovation officer at Boston Children’s Hospital and an ABC News contributor, noted that it aligns with observations of electronic medical record data.

“So, we’re seeing, for the first time in decades, that there’s like a leveling off and even maybe a slight decrease and I think this is like challenging a major shift from the long-held expectation that obesity would just be climbing year after year,” he said.

According to Brownstein, the decrease is likely due to many factors including public health policies and education about healthier lifestyles as well as medications such as GLP-1s.

GLP-1s, or glucagon-like peptide-1 receptor agonists, mimic the GLP-1 hormone that is produced in the gut after eating.

It can help produce more insulin, which reduces blood sugar and therefore helps control Type 2 diabetes. It can also interact with the brain and signal a person to feel full, which — when coupled with diet and exercise — can help reduce weight in those who are overweight or obese.

Many GLP-1s have become household names, including Ozempic, Wegovy, Mounjaro, Zepbound and Trulicity.

“I do think the advent of the GLP-1s are absolutely playing a role,” Brownstein said. “At that point in 2023, they weren’t as widespread as they are today. So, we expect that these factors could play even more significant role in more recent times.”

Dr. Justin Ryder, an associate professor of surgery and pediatrics at Northwestern Feinberg School of Medicine, said he’s cautiously optimistic about the slight decrease.

However, he added that it remains to be seen whether this is a blip or if the decrease is indicative of a longer-term trend.

“We’ve seen dips in the past and typically, when they do, in the next reporting period it goes right back up,” Ryder told ABC News. “And that’s because of how the sampling is done. This is a random sample of U.S. adults.”

He noted that the random sampling makes it difficult to draw firm conclusions.

“Could it just be the people who were sampled, or is it real?” he said. “And I think we won’t know that until we have another set or a larger set of data over either the same sampling period or a couple more years from now.”

Meanwhile, a second report found that more than one in five U.S. children and teenagers have obesity, which is the highest figure ever recorded.

The survey conducted between August 2021 and August 2023 found 21.1% of U.S. children and teenagers between ages 2 and 19 have obesity, up from 5.2% during the 1971-1974 survey.

Additionally, 7% of children live with severe obesity, an increase from the 1% seen 50 years ago, according to the report.

“This is exceptionally concerning,” Dr. David Ludwig, co-director of the New Balance Foundation Obesity Prevention Center at Boston Children’s Hospital and professor of nutrition at Harvard School of Public Health, told ABC News.

He added that in the 1970s, “children were certainly recognized (as obese) but it was the rare child, one in 20. And now we’re looking at one in five children with obesity.”

Ludwig said it had seemed for a short period of time that the prevalence of obesity was decreasing at least among 2-to-5-year-olds when rates declined from 12.1% in 2009-2010 to 9.4% in 2013-2014.

At the time, he viewed it as a “glimmer of hope” — but rates increased again and now sit at 14.9% for this age group.

“We saw that dip and we all got excited thinking that we were beginning to turn the tide,” Ludwig said. “In retrospect, that was more of a statistical aberration, more of mirage than a true glimmer of hope because the trend overall has continued upward.”

To reverse the trends among children, Ryder said the 2-to-5-year-old group will need lifestyle modifications such as healthier eating. The 6-to-11-year-old group will need similar methods although some medications are available, he said.

For children above age 12, Ryder said medications and bariatric surgery are options.

Nearly 23% of children ages 12 to 19 were considered obese in the most recent survey. Ryder said that means they meet the guidelines for intensive treatment, whether that’s lifestyle adjustments or in combination with medications or surgery.

“I think the only way that we’re going to see a downward trend in that number is if we take that adolescent group of 12- to 19-year-olds and actually start to apply the clinical practice guidelines and treat those kids seriously, offering them medications,” he said.

Ishani D. Premaratne, MD, is an integrated plastic & reconstructive surgery resident and member of the ABC News Medical Unit.